| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/22/2001 | WO2001012181A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 02/22/2001 | WO2001012155A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 02/22/2001 | WO2000078941A3 Methods and products for manipulating uncoupling protein expression |
| 02/22/2001 | WO2000077179A3 Human poly(adp-ribose) polymerase 2 materials and methods |
| 02/22/2001 | WO2000072863A3 Uses of h-trek-1 polypeptides and polynucleotides encoding them |
| 02/22/2001 | WO2000071538A3 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/22/2001 | WO2000071514A8 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS |
| 02/22/2001 | WO2000069470A3 Improved cellular uptake of bioactive agents |
| 02/22/2001 | WO2000062788A3 Treatment of hypersensitivity reaction disorders |
| 02/22/2001 | WO2000058314A3 Sulfamate containing macrocyclic immunomodulators |
| 02/22/2001 | WO2000055126A3 N-cyanomethylamides as protease inhibitors |
| 02/22/2001 | WO1999063996A8 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht2 receptors |
| 02/22/2001 | WO1999046279A3 INHIBITORS OF TYPE 5 AND TYPE 3 17β-HYDROXYSTEROID DEHYDROGENASE AND METHODS FOR THEIR USE |
| 02/22/2001 | DE19939463A1 Tryptase inhibitors useful e.g. for treating inflammatory or allergic disease, arteriosclerosis or neoplasia, comprising new or known 2-phenethyl-benzimidazole-5-carboxamides |
| 02/22/2001 | CA2391319A1 Water soluble sdz-rad esters |
| 02/22/2001 | CA2383268A1 Pyrazoloanthrone and derivatives thereof as jnk inhibitors and their compositions |
| 02/22/2001 | CA2382749A1 Amines substituted with a dihydro-isobenzofuranyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological activity |
| 02/22/2001 | CA2382148A1 25 human secreted proteins |
| 02/22/2001 | CA2382095A1 Methods of inhibiting binding of .beta.-sheet fibril to rage and consequences thereof |
| 02/22/2001 | CA2382019A1 Isomerase proteins |
| 02/22/2001 | CA2382018A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | CA2381971A1 Amines substituted with a tetrahydroquinolinyl group, an aryl or heteroaryl group and an alkyl group, having retinoid-like biological acitity |
| 02/22/2001 | CA2381794A1 Helical cytokine zalpha48 |
| 02/22/2001 | CA2381551A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/22/2001 | CA2380979A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 02/22/2001 | CA2380940A1 Substances and agents for positively influencing collagen |
| 02/22/2001 | CA2380817A1 Cell adhesion inhibitors |
| 02/22/2001 | CA2380786A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/22/2001 | CA2380642A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 02/22/2001 | CA2379647A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 02/22/2001 | CA2378332A1 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/22/2001 | CA2377662A1 Novel protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | CA2377646A1 Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/21/2001 | EP1077064A1 Use of peroxidised lipids as lipidic film forming agents on the skin |
| 02/21/2001 | EP1077063A2 Methods for treating skin pigmentation |
| 02/21/2001 | EP1076659A1 Paroxetine 10-camphorsulfonate for treatment of cns disorders |
| 02/21/2001 | EP1076563A1 Dipeptide caspase inhibitors and the use thereof |
| 02/21/2001 | EP1076557A1 Ccr-3 receptor antagonists |
| 02/21/2001 | EP0988029A4 Device and methods for wound treatment |
| 02/21/2001 | CN1284957A Imidazonaphthyridines and their use in inducing cytokine biosynthesis |
| 02/21/2001 | CN1284954A Benzo[c]quinolizine derivatives and their use as 5 alpha-reductases inhibitors |
| 02/21/2001 | CN1284947A Carboxyl acid substituted heterocycles as metalloproteinase inhibitors |
| 02/21/2001 | CN1284944A Integrin receptor antagonists |
| 02/21/2001 | CN1284942A Matrix metalloprotease inhibitors |
| 02/21/2001 | CN1284870A Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthritis, neurodermatitis and regional enteritis |
| 02/21/2001 | CN1284494A Bamboo parasitic fungus extract and its preparation and application |
| 02/21/2001 | CN1284381A Recombined human interferon alpha gel preparation and its production process |
| 02/21/2001 | CN1284345A Plaque dispelling mixture |
| 02/21/2001 | CN1284339A Acne-eliminating and beautifying toad cake ointment |
| 02/21/2001 | CN1284325A Composition for treating scurf, psoriasis and eczema |
| 02/21/2001 | CN1284324A Serial products capable of treating seborrheic baldness, eliminating scurf and stopping head itching |
| 02/21/2001 | CN1062171C Application of patchouli oil used as germicide for skin |
| 02/21/2001 | CN1062162C External use ointment for treatment of cutaneous pigmentation |
| 02/21/2001 | CN1062153C Medicine for acne and its preparation |
| 02/21/2001 | CN1062152C Aldehyde-olefin scald medicine liquid |
| 02/21/2001 | CN1062147C Zuochuangjing-external use medicine for treating acne |
| 02/21/2001 | CN1062140C Method for extracting earthworm element from Japan Dula earthworm |
| 02/21/2001 | CN1062130C Medical liposome ointment |
| 02/21/2001 | CN1062129C Medicine matrix and its use |
| 02/21/2001 | CN1062128C Ointment for eliminating tinea |
| 02/21/2001 | CN1062127C Freckle dispelling powder |
| 02/20/2001 | US6191339 Thermal effect patch and the use thereof |
| 02/20/2001 | US6191301 Protecting the human epidermis or human hair from ultraviolet radiation, both the a and b rays, specifically in the range from 320 to 400 nm; protect other ingredients from decomposition or breakdown by uv radiation; |
| 02/20/2001 | US6191271 Synthetic divalent sLex containing polylactosamines and methods for use |
| 02/20/2001 | US6191147 Pyrazole compounds and uses thereof |
| 02/20/2001 | US6191135 Respiratory system disorders, antiinflammatory agents; analgesics |
| 02/20/2001 | US6191125 Small molecule pipecolic acid derivative hair growth compositions and uses |
| 02/20/2001 | US6191121 Treatment of skin damage using polyenylphosphatidylcholine |
| 02/20/2001 | US6190880 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 02/20/2001 | US6190875 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 02/20/2001 | US6190869 Antisense inhibition of protein kinase C-theta expression |
| 02/20/2001 | US6190674 Mild, rinse-off, personal cleansing formulation; for treating acne; effective against gramnegative bacteria |
| 02/20/2001 | CA2223624C Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-.alpha.]pyridines |
| 02/20/2001 | CA2192289C Substituted heterocyclic derivatives |
| 02/20/2001 | CA2191789C Biaromatic compounds containing an adamantyl group in ortho position; pharmaceutical and cosmetic compositions containing them and use thereof |
| 02/20/2001 | CA2060208C Wound healing |
| 02/20/2001 | CA1341182C Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011041A1 MONOMERIC PROTEIN OF THE TGF-β FAMILY |
| 02/15/2001 | WO2001010987A1 Grapeseed, cold-pressed grape oil, crushed grape and grape flour |
| 02/15/2001 | WO2001010867A1 Vitronectin receptor antagonists useful for the treatment of strokes |
| 02/15/2001 | WO2001010866A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 02/15/2001 | WO2001010859A1 Substituted pyridazines and fused pyridazines with angiogenesis inhibiting activity |
| 02/15/2001 | WO2001010847A2 Novel integrin receptor antagonists |
| 02/15/2001 | WO2001010842A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 02/15/2001 | WO2001010838A1 Multivalent compounds |
| 02/15/2001 | WO2001010837A1 Multivalent sulfonamides |
| 02/15/2001 | WO2001010829A1 Novel vitamin d analogues |
| 02/15/2001 | WO2001010821A1 Multivalent exocyclic diketo compounds |
| 02/15/2001 | WO2001010455A1 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 02/15/2001 | WO2001010430A2 Use of estrogen compounds for prevention and treatment of ischemic damage |
| 02/15/2001 | WO2001010427A2 Use of anti-muscarinic agents for treating skin disorders |
| 02/15/2001 | WO2001010413A2 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 02/15/2001 | WO2001010383A2 Caspase inhibitors and uses thereof |
| 02/15/2001 | WO2001010381A2 Methods for treating or preventing pain and anxiety |
| 02/15/2001 | WO2000069884A3 Compositions isolated from skin cells and methods for their use |
| 02/15/2001 | WO2000066584B1 1-AMINO TRIAZOLO¢4,3-a! QUINAZOLINE-5-ONES AND OR -5-THIONES INHIBITING PHOSPHODIESTERASE IV |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000064874A3 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
| 02/15/2001 | WO2000062740A3 Skin care compositions containing combination of skin care actives |